The Patent Finder

Maintenance fees coming due

Supernus Pharmaceuticals, Inc.

8 maintenance fees come due in the 12 months from Nov 15, 2026, the next on Dec 11, 2026. Unpaid by Jun 11, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.
PatentTitleHolderStatusFee dueLapses if unpaidExpiresConfidence
US 10,314,790Sustained-Release Formulations of Topiramate
In force
Fee due Dec 11, 2026
Lapses if unpaid Jun 11, 2027
 · Medium confidence
Supernus Pharmaceuticals, Inc.In forceDec 11, 2026Jun 11, 2027Medium confidence
US 11,679,090Modulators of SESTRIN-GATOR2 Interaction and Uses Thereof
In force
Fee due Dec 20, 2026
Lapses if unpaid Jun 21, 2027
 · High confidence
Supernus Pharmaceuticals, Inc.In forceDec 20, 2026Jun 21, 2027High confidence
US 11,697,633Polymorphic Compounds and Uses Thereof
In force
Fee due Jan 11, 2027
Lapses if unpaid Jul 12, 2027
 · Medium confidence
Supernus Pharmaceuticals, Inc.In forceJan 11, 2027Jul 12, 2027Medium confidence
US 11,723,890METHODS OF TREATMENT USING AN mTORC1 MODULATOR
In force
Fee due Feb 15, 2027
Lapses if unpaid Aug 16, 2027
 · High confidence
Supernus Pharmaceuticals, Inc.In forceFeb 15, 2027Aug 16, 2027High confidence
US 10,414,782Modulators of SESTRIN-GATOR2 Interaction and Uses Thereof
In force
Fee due Mar 17, 2027
Lapses if unpaid Sep 17, 2027
 · High confidence
Supernus Pharmaceuticals, Inc.In forceMar 17, 2027Sep 17, 2027High confidence
US 11,911,368Method of Treatment of CNS Disorders
In force
Fee due Aug 27, 2027
Lapses if unpaid Feb 28, 2028
 · High confidence
Supernus Pharmaceuticals, Inc.In forceAug 27, 2027Feb 28, 2028High confidence
US 11,919,889Derivatives of Substituted Morpholines and Uses Thereof
In force
Fee due Sep 5, 2027
Lapses if unpaid Mar 6, 2028
 · High confidence
Supernus Pharmaceuticals, Inc.In forceSep 5, 2027Mar 6, 2028High confidence
US 11,964,951Process of Making Derivatives of Substituted Morpholines
In force
Fee due Oct 23, 2027
Lapses if unpaid Apr 24, 2028
 · High confidence
Supernus Pharmaceuticals, Inc.In forceOct 23, 2027Apr 24, 2028High confidence
8 of 8 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited